Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthopediatrics (KIDS) EBT (2016 - 2026)

Orthopediatrics has reported EBT over the past 11 years, most recently at -$10.9 million for Q1 2026.

  • For Q1 2026, EBT fell 3.78% year-over-year to -$10.9 million; the TTM value through Mar 2026 reached -$39.6 million, up 5.88%, while the annual FY2025 figure was -$39.2 million, 6.54% up from the prior year.
  • EBT for Q1 2026 was -$10.9 million at Orthopediatrics, down from -$9.8 million in the prior quarter.
  • Over five years, EBT peaked at $14.4 million in Q3 2022 and troughed at -$16.4 million in Q4 2024.
  • A 5-year average of -$6.9 million and a median of -$7.9 million in 2022 define the central range for EBT.
  • On a YoY basis, EBT climbed as much as 678.38% in 2022 and fell as far as 4656.63% in 2022.
  • Year by year, EBT stood at -$7.9 million in 2022, then increased by 12.58% to -$6.9 million in 2023, then plummeted by 137.71% to -$16.4 million in 2024, then soared by 40.5% to -$9.8 million in 2025, then decreased by 11.22% to -$10.9 million in 2026.
  • Business Quant data shows EBT for KIDS at -$10.9 million in Q1 2026, -$9.8 million in Q4 2025, and -$11.9 million in Q3 2025.